FGFR4 and hyperphosphatemia: In contrast to FGF23 neutralizing antibodies and prolonged pan-FGFR blockade that have been shown to cause hyperphosphatemia, tissue calcification and increased mortality27, 28, the specific FGFR4 blocking antibody did not interfere with serum phosphate levels.